MERIDIAN BIOSCIENCE INC
DelistedCIK 794172fmd_1JHN5GNR21H1YDE1DQYCKVB3K2Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Oct 01, 2007 to Dec 31, 2022, 56 periods
Latest annual · FY2022
Millions- Total revenues
- 333
- Gross profit
- 188
- Operating income
- 54
- Net income
- 42
- Free cash flow
- 74
Latest quarter · Q1 FY2023
Millions- Total revenues
- 57
- Gross profit
- 32
- Operating income
- (28)
- Net income
- (30)
- Free cash flow
- (5)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- +18.3%
- Revenue, 5 yearsFY2017 to FY2022
- +10.7%
- Net income, 5 yearsFY2017 to FY2022
- +14.5%
MERIDIAN BIOSCIENCE INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $333 million | $317.9 million | +4.8% | 10-K 2022-11-22 · proof |
| Gross profit | $188.4 million | $201.1 million | -6.4% | 10-K 2022-11-22 · proof |
| Operating income | $54.4 million | $93 million | -41.5% | 10-K 2022-11-22 · proof |
| Net income | $42.5 million | $71.4 million | -40.5% | 10-K 2022-11-22 · proof |
| Cash from operating activities | $82.4 million | $66.9 million | +23.2% | 10-K 2022-11-22 · proof |
| Free cash flow | $73.7 million | $48.6 million | +51.9% | 10-K 2022-11-22 · proof |
| Total assets | $463.1 million | $449.7 million | +3% | 10-K 2022-11-22 · proof |
| Total liabilities | $95 million | $121.4 million | -21.7% | 10-K 2022-11-22 · proof |
| Cash and cash equivalents | $81.5 million | $49.8 million | +63.7% | 10-K 2022-11-22 · proof |
- What was MERIDIAN BIOSCIENCE INC's revenue in fiscal 2022?
- MERIDIAN BIOSCIENCE INC reported revenue of $333 million for fiscal 2022 (the year ended Sep 30, 2022), against $317.9 million the year before (+4.8%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What was MERIDIAN BIOSCIENCE INC's gross profit in fiscal 2022?
- MERIDIAN BIOSCIENCE INC reported gross profit of $188.4 million for fiscal 2022 (the year ended Sep 30, 2022), against $201.1 million the year before (-6.4%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What was MERIDIAN BIOSCIENCE INC's operating income in fiscal 2022?
- MERIDIAN BIOSCIENCE INC reported operating income of $54.4 million for fiscal 2022 (the year ended Sep 30, 2022), against $93 million the year before (-41.5%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What was MERIDIAN BIOSCIENCE INC's net income in fiscal 2022?
- MERIDIAN BIOSCIENCE INC reported net income of $42.5 million for fiscal 2022 (the year ended Sep 30, 2022), against $71.4 million the year before (-40.5%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What was MERIDIAN BIOSCIENCE INC's cash from operating activities in fiscal 2022?
- MERIDIAN BIOSCIENCE INC reported cash from operating activities of $82.4 million for fiscal 2022 (the year ended Sep 30, 2022), against $66.9 million the year before (+23.2%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What was MERIDIAN BIOSCIENCE INC's free cash flow in fiscal 2022?
- MERIDIAN BIOSCIENCE INC reported free cash flow of $73.7 million for fiscal 2022 (the year ended Sep 30, 2022), against $48.6 million the year before (+51.9%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What are MERIDIAN BIOSCIENCE INC's total assets?
- As of Sep 30, 2022, MERIDIAN BIOSCIENCE INC reported total assets of $463.1 million, against $449.7 million a year earlier (+3%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What are MERIDIAN BIOSCIENCE INC's total liabilities?
- As of Sep 30, 2022, MERIDIAN BIOSCIENCE INC reported total liabilities of $95 million, against $121.4 million a year earlier (-21.7%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
- What are MERIDIAN BIOSCIENCE INC's cash and cash equivalents?
- As of Sep 30, 2022, MERIDIAN BIOSCIENCE INC reported cash and cash equivalents of $81.5 million, against $49.8 million a year earlier (+63.7%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:794172&period_type=annual&limit=5"Information only, not investment advice.